Provided by Tiger Fintech (Singapore) Pte. Ltd.

JW THERAP-B

2.950
+0.0702.43%
Volume:2.88M
Turnover:8.63M
Market Cap:1.23B
PE:-1.89
High:3.110
Open:2.890
Low:2.880
Close:2.880
Loading ...

Company Profile

Company Name:
JW THERAP-B
Exchange:
SEHK
Establishment Date:
2016
Employees:
281
Office Location:
Building B,5th Floor,No. 699 Zhong Ke Road,Pudong New District,Shanghai,China
Website:
- -
Zip Code:
- -
Fax:
- -
Introduction:
JW (Cayman) Therapeutics Co Ltd is a company primarily engaged in research and development, manufacturing, and marketing of cellular immunotherapy products. The Company has built an integrated platform for product development in cell immunotherapy, as well as a product pipeline covering hematologic malignancies, solid tumors and autoimmune diseases. The Company’s main product, Carteyva, is an autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) cell immunotherapy product independently developed by the Company based on a CAR-T cell process platform of Juno (a Bristol Myers Squibb company). The Company mainly conducts its business in the domestic market.

Directors

Name
Position
LIU Min
Chairman of the Board,Executive Director,Member of the Strategic and Development Committee,Member of the Nomination Committee
HE Jian Chang
Independent Director,Chairman of the Nomination Committee,Audit Committee Chairman
Debra Yu
Independent Director,Chairman of the Strategic and Development Committee,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
CHEN Bing Jun
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Member
GAO Xing
Director,Member of the Strategic and Development Committee,Audit Committee Member
LIU Cheng
Director
Sungwon Song
Director,Member of the Remuneration and Assessment Committee
LI Yi Ping
Director

Shareholders

Name
Position
LIU Min
CEO
FU Xin
Vice General Manager
ZHENG Hong Xia
Vice General Manager
SUN Wen Jun
Vice General Manager
MA Qiang
Vice General Manager,Chief Business Officer
QIN Yun
Vice General Manager
LIN Li Yuan
CTO,Other Senior Executives
WU Jia Wen
Corporate Secretary
WU Qiong
Chief Business Officer
Shaun Paul Cordoba
Chief Science Officer
YANG Su
Other Senior Executives
Raymond J. Hage, Jr.
Other Senior Executives